CJEU landmark ruling confirms that CBD is not a narcotic drug and that member states may not prohibit its marketing

Published date20 November 2020
Subject MatterCannabidiol (CBD) oil,EU,Hemp,CJEU
AuthorEveline Van Keymeulen
Law FirmAllen & Overy LLP

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT